longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Radnet

RDNT

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -267.63, within the reasonable range, cheaper than 75.52% of the time in the past 5 years, and the industry ranks 61/74, the industry Median --.

-267.63xP/E
$71.81Stock price
$-0.27Earnings per share
-267.63xP/E
Stock price$71.81Earnings per share$-0.27

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
47.88x
Typical range
-308.30x–467.19x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
07142128

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
GHUSGuardant Health
-52.48x2.92%$23.80B
HIMSUSHims & Hers Health
-47.28x209.86%$6.71B
RDNTUSRadnet
-267.63x128.00%$5.65B
WGSUSGeneDx
-24.09x359.59%$2.56B
NEOUSNeogenomics
-47.77x64.73%$2.48B
AGLUSagilon health
-5.75x92.48%$1.34B
OPKUSOpko Health
-16.69x25.44%$1.22B
INNVUSInnovage
-478.14x2,301.70%$1.21B
CSTLUSCastle Biosciences
-56.54x52.61%$1.10B
LMRIUSLumexa Imaging
-35.15x145.51%$974.68M
FLGTUSFulgent Genetics
-7.29x42.64%$615.24M
GMRSUSGMR Solutions
-7.16x91.45%$541.30M
PREUSPrenetics Global
-8.30x16.63%$390.19M
AONCUSAmerican Oncology Network
----$337.32M
BDSXUSBiodesix
-11.56x42.77%$320.97M
GAMGUSGlobal Asset Management Group, Inc.
-319.72x--$180.46M
NAKAUSNakamoto
-0.41x102.50%$173.94M
AIRSUSAirSculpt Tech
-11.55x33.33%$135.54M
CORBFUSGlobal Cord Blood Corporation
----$127.35M
PARKUSPark Dental Partners
-26.59x--$94.01M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.